• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Paige Unveils AI Co-Pilot for Pathology & Oncology, Paige Alba

by Fred Pennic 09/05/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Paige, a provider of next-generation artificial intelligence has introduced Paige Alba, a groundbreaking clinical-grade multimodal co-pilot designed to transform personalized medicine and precision oncology. 

– Leveraging the power of Paige’s Foundation Models, Alba delivers real-time AI-driven patient insights, marking a significant step towards Artificial General Intelligence (AGI).

A Cohesive Solution for Personalized Medicine

Paige Alba seamlessly integrates state-of-the-art computational pathology large vision models (LVMs) with conversational large language models (LLMs). This unique combination provides a comprehensive and interactive experience for pathologists, oncologists, multidisciplinary clinical teams, and clinical trial management.  

Key features of Paige Alba include: 

  • Data Aggregation: Combines patient data from various sources, including EHRs, LIS, and IMS, into a single, cohesive view.
  • Real-time Insights: Provides instant access to comprehensive patient summaries, eliminating the need to navigate multiple platforms.
  • Enhanced Decision-Making: Supports pathologists in providing diagnostic recommendations by analyzing clinical, pathological, and biomarker data.
  • Automated Report Generation: Generates pathology reports using voice commands, streamlining the diagnostic process.

Revolutionizing the Pathology Workflow

Paige Alba offers significant benefits for pathology laboratories:

  • Increased Efficiency: Reduces administrative tasks and allows pathologists to focus on core responsibilities.
  • Improved Accuracy: Leveraging AI to analyze digital images enhances diagnostic accuracy.
  • Enhanced Collaboration: Facilitates collaboration among pathologists, oncologists, and other healthcare professionals.
  • Personalized Medicine: Enables more personalized treatment plans based on comprehensive patient data.

“Integrating multiple AI technologies and capabilities into a single system in this way has the potential to support complex decision making in cancer patients. In the same way that even the best airline pilots rely on co-pilots to gather data and guide decision-making, Alba ensures that clinicians are supported and guided with the most relevant, timely, and comprehensive information,” said Razik Yousfi, CTO and CEO of Paige. “With Alba, we are not just enhancing diagnostic precision—we are empowering clinicians with a truly intelligent and interactive co-pilot.”

Paige Alba™ is for research use only (RUO), not for use in diagnostic procedures.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Digital Pathology, Oncology

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Research Report

2026 Best in KLAS Awards: The Full List of Software & Services Winners

Most-Read

The "Platform" Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

The “Platform” Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

Analysis: Oracle Cerner’s Plans for a National EHR

Oracle May Cut 30k Jobs and Sell Cerner to Fund $156B OpenAI Deal

The $1.9B Exit: Why CommonSpirit is Insourcing Revenue Cycle and Tenet is Betting Big on Conifer AI

The $1.9B Exit: Why CommonSpirit is Insourcing Revenue Cycle and Tenet is Betting Big on Conifer AI

KLAS 2026 Rankings: Aledade and Guidehealth Named Top VBC Enablement Firms

KLAS 2026 Rankings: Aledade and Guidehealth Named Top VBC Enablement Firms

Beyond the Hype: New KLAS Data Validates the Financial and Clinical ROI of Ambient AI

Beyond the Hype: New KLAS Data Validates the Financial and Clinical ROI of Ambient AI

Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences

Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences

OpenAI Debuts ChatGPT Health: A ‘Digital Front Door’ That Connects Medical Records to Agentic AI

OpenAI Debuts ChatGPT Health: A ‘Digital Front Door’ That Connects Medical Records to Agentic AI

From Genes to Hackers: The Hidden Cybersecurity Risks in Life Sciences

From Genes to Hackers: The Hidden Cybersecurity Risks in Life Sciences

Utah Becomes First State to Approve AI System for Prescription Renewals

Utah Becomes First State to Approve AI System for Prescription Renewals

NYC Health + Hospitals to Acquire Maimonides in $2.2B Safety Net Overhaul

NYC Health + Hospitals to Acquire Maimonides in $2.2B Safety Net Overhaul

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |